Australians are invited to provide feedback on options proposed for modernising Australia's regulatory framework for measurement.
The antiviral drug remdesivir is not recommended for patients admitted to hospital with COVID-19, regardless of how severely ill they are.
Good manufacturing practice (GMP) regulators have sharpened their focus on warehouse storage and distribution practices.
Australian laboratories are subject to major audits every two to four years, with all necessary documentation checked to ensure that laboratories are meeting industry accredited standards.
New laws are required to control access to medical genetic data by law enforcement agencies, according to researchers at the University of Queensland.
Bioethicist Dr Ainsley Newson talks mitochondrial donation, targeted testing and other ethical dilemmas ahead of the AACB AIMS 2018 Combined Scientific Meeting.
Australian women at risk of having babies suffering severe mitochondrial disease may soon be able to have healthy children.
The Australian Government has released its new national security science and technology policy agenda, aimed at strengthening Australia's national security.
Cayman Chemical's MaxSpec Lipidomics Standards help achieve the accuracy and reproducibility required by lipidomics research.
Researchers have recommended changes to the guidelines used in clinical trials, in an effort to gain information about the impact on the quality of life of participating patients.
The Australian Government has announced that it will permit the export of medicinal cannabis products.
The ACCC has instituted proceedings in the Federal Court of Australia against GlaxoSmithKline Healthcare Australia and Novartis Consumer Health Australasia, alleging they made false or misleading representations in the marketing of Voltaren Osteo Gel and Emulgel pain relief products.
University of Birmingham researchers have identified new mechanisms used by bacteria to resist antibiotics, just days after one of their number voiced her concern surrounding the EU and UK's action plans to fight antibiotic-resistant infections.
Under the various guidelines that relate to asbestos there are numerous requirements, implicit and explicit, for laboratories reporting asbestos testing results.
Sirtex Medical has paid a penalty of $100,000 after the Australian Securities and Investments Commission issued an infringement notice for an alleged failure by the company to comply with its continuous disclosure obligations.